Completely agree, and we need max SP impact when we submit final BLA application. IF clinical was ready last week and the market was tanking...makes sense to submit the whole package and drum up more eyes on CYDY with COVID/Cancer PRs in anticipation of both Clinical and manufacturing being completed by EOM and submission of parts 2 and 3 once market has stabilized a bit. Just my opinion...